- Case report
- Open Access
- Open Peer Review
Capsule impaction presenting as acute small bowel perforation: a case series
© De Palma et al.; licensee BioMed Central Ltd. 2012
- Received: 27 October 2011
- Accepted: 3 May 2012
- Published: 3 May 2012
Perforation caused by capsule endoscopy impaction is extremely rare and, at present, only five cases of perforation from capsule endoscopy impaction are reported in the literature.
We report here two cases of patients with undiagnosed small bowel stenosis presenting with acute perforation after capsule endoscopy. Strictures in the small bowel were likely the inciting mechanism leading to acute small bowel obstruction and subsequent distension and perforation above the capsule in the area of maximal serosal tension.
Case 1 was a 55-year-old Italian woman who underwent capsule endoscopy because of recurrent postprandial cramping pain and iron deficiency anemia, in the setting of negative imaging studies including an abdominal ultrasound, upper endoscopy, colonoscopy and small bowel follow-through radiograph. She developed a symptomatic bowel obstruction approximately 36 hours after ingestion of the capsule. Emergent surgery was performed to remove the capsule, which was impacted at a stenosis due to a previously undiagnosed ileal adenocarcinoma, leading to perforation.
Case 2 was a 60-year-old Italian man with recurrent episodes of abdominal pain and diarrhea who underwent capsule endoscopy after conventional modalities, including comprehensive blood and stool studies, computed tomography, an abdominal ultrasound, upper endoscopy, colonoscopy, barium enema and small bowel follow-through, were not diagnostic. Our patient developed abdominal distension, acute periumbilical pain, fever and leukocytosis 20 hours after capsule ingestion. Emergent surgery was performed to remove the capsule, which was impacted at a previously undiagnosed ileal Crohn’s stricture, leading to perforation.
The present report shows that, although the risk of acute complication is very low, the patient should be informed of the risks involved in capsule endoscopy, including the need for emergency surgical exploration.
- Small Bowel
- Iron Deficiency Anemia
- Capsule Endoscopy
- Small Bowel Perforation
- Patency Capsule
Small bowel capsule endoscopy (CE) has become a commonly performed diagnostic test in patients affected by various small bowel diseases.
Impaction of the video capsule in the small bowel is a potential serious complication of this procedure, occurring in 0.75% to 21% of cases as reported by previous studies; its incidence rate is greatly dependent on procedural indication and patient characteristics [1, 2]. Small bowel perforation due to CE impaction is extremely rare and, to date, only five cases have been reported in the literature [3–7].
We report here two cases of patients with previously undiagnosed small bowel stenosis presenting with acute perforation as a result of capsule impaction.
A 55-year-old Italian woman was referred to our division when she complained of severe cramping abdominal pain and vomiting approximately 36 hours after ingestion of a capsule endoscope.
A 60-year-old Italian man arrived at our department with abdominal distension and acute periumbilical pain. Over the two preceding years, our patient had undergone an extensive negative workup performed for recurrent episodes of abdominal pain and diarrhea, including comprehensive blood and stool studies, CT, abdominal ultrasound, esophogastroduodenoscopy, colonoscopy, barium enema and small bowel follow-through. Twenty-four hours prior to his arrival, our patient had undergone CE, the results of which were still pending.
On admission, our patient was febrile. His physical examination revealed a distended abdomen with increased bowel sounds and marked tenderness in the right lower quadrant. Laboratory tests showed a white blood cell count of 16,300 cells/mL (normal: 4,500 to 10,500 cells/mL) and hemoglobin of 10.7g/dL (normal: 12g/dL to 16g/dL).
CE is a safe and well-tolerated procedure. To date, in clinical practice, the risk of capsule retention at the site of a previously unknown small bowel stricture remains the main complication of CE. The International Conference on Capsule Endoscopy consensus defined capsule impaction as retention of a capsule endoscope in the small bowel for a minimum of two weeks or as capsule retention in the bowel for a shorter period requiring medical, endoscopic or surgical intervention . The frequency of capsule retention seems to be dependent mostly on the clinical indication for CE, ranging from 0% in healthy patients to 21% in patients with small bowel stricture. Larger single institution studies reported an impaction rate of up to 2.5% [1, 2, 9, 10]. Capsule impaction usually occurs at sites of structural abnormality in the small bowel, usually ulcers, masses or strictures caused by Crohn’s disease, non-steroidal anti-inflammatory drugs use, radiation enteritis or surgical anastomosis.
In previously reported cases of capsule impaction, patients have generally been asymptomatic, even when the capsule has remained impacted for a very long time. However, some case reports described the possibility of acute obstruction or perforation due to capsule retention.
Patients with abdominal pain, distension and vomiting after CE should be evaluated for impaction and small bowel obstruction or perforation. The diagnosis may be aided by examination of capsule images, which can reveal an obstructing lesion, or show repetitive images of the same area of mucosa. Abdominal radiography or CT will typically demonstrate the retention of the capsule in the small bowel in association with signs of bowel distension or perforation.
To date, there have been five documented cases of small bowel perforation caused by an impacted capsule retention [3–7]. Perforation due to capsule retention occurred in four patients with Crohn’s disease and in one patient with visceral adhesions. Perforation happened from one day after ingestion of the capsule to two months after retention.
In the present cases, perforation occurred within 60 hours and 20 hours of the capsule ingestion in a patient with undiagnosed ileal adenocarcinoma and in a patient with undiagnosed Crohn’s disease, respectively. Strictures in the small bowel were likely the inciting mechanism leading to acute small bowel obstruction and subsequent distension and perforation above the capsule in the area of maximal serosal tension.
Our patients had no history of obstructive symptoms and both had undergone extensive diagnostic work up before the CE, including negative comprehensive blood, endoscopic and radiological studies. Our case series supports previous claims that barium studies have limited sensitivity for predicting capsule passage. CT or magnetic resonance imaging enteroclysis are being investigated as potential alternative screening methods, with promising results. There is, however, no accepted method to safely avoid capsule retention at present .
A newly designed non-visualizing dissolvable capsule (patency capsule: Given Imaging, Yoqneam, Israel) has been developed to minimize the risk of retention. This device starts its dissolution process 30 hours after ingestion even if one end of the capsule is impacted in a stricture. The patency capsule has been used as a screening test to assess the passage of an endoscopic capsule in patients at risk for small bowel strictures. There has been concern, however, about the efficacy and safety of this device because the patency capsule itself has also been shown to result in symptomatic small bowel obstruction in a few cases .
In conclusion, although the risk of acute complication is very low, the patient should be informed of the risks involved in CE, including the potential need for emergency surgical exploration.
Written informed consent was obtained from the patients for publication of this manuscript and accompanying images. Copies of the written consent are available for review by the Editor-in-Chief of this journal.
- Rondonotti E, Herrerias JM, Pennazio M, Caunedo A, Mascarenhas-Saraiva M, de Franchis R: Complications, limitations, and failures of capsule endoscopy: a review of 733 cases. Gastrointest Endosc. 2005, 62: 712-716. 10.1016/j.gie.2005.05.002.View ArticlePubMedGoogle Scholar
- Rondonotti E, Villa F, Mulder CJJ, Jacobs MAJM, de Franchis R: Small bowel capsule endoscopy in 2007: indications, risks and limitations. World J Gastroenterol. 2007, 13 (46): 6140-6149. 10.3748/wjg.13.6140.View ArticlePubMedPubMed CentralGoogle Scholar
- Gonzalez Carro P, Picazo Yuste J, Fernández Díez S, Pérez Roldán F, Roncero García-Escribano O: Intestinal perforation due to retained capsule endoscope. Endoscopy. 2005, 37: 684-10.1055/s-2005-861424.View ArticlePubMedGoogle Scholar
- Lin OS, Brandabur JJ, Schembre DB, Soon MS, Kozarek RA: Acute symptomatic small bowel obstruction due to capsule impaction. Gastrointest Endosc. 2007, 65: 725-728. 10.1016/j.gie.2006.11.033.View ArticlePubMedGoogle Scholar
- Um S, Poblete H, Zavotsky J: Small bowel perforation caused by an impacted endocapsule. Endoscopy. 2008, 40: E122-E123. 10.1055/s-2007-995694.View ArticlePubMedGoogle Scholar
- Repici A, Barbon V, De Angelis C, Luigiano C, De Caro G, Hervoso C, Danese S, Preatoni P, Pagano N, Comunale S, Pennazio M, Rizzetto M: Acute small-bowel perforation secondary to capsule endoscopy. Gastrointest Endosc. 2008, 67: 180-183. 10.1016/j.gie.2007.05.044.View ArticlePubMedGoogle Scholar
- Parikh DA, Parikh JA, Albers GC, Chandler CF: Acute small bowel perforation after wireless capsule endoscopy in a patient with Crohn’s disease: a case report. Cases J. 2009, 2: 7607-10.4076/1757-1626-2-7607.View ArticlePubMedPubMed CentralGoogle Scholar
- Cave D, Legnani P, de Franchis R, Lewis BS, ICCE: ICCE consensus for capsule retention. Endoscopy. 2005 Oct, 37 (10): 1065-1067. 10.1055/s-2005-870264.View ArticlePubMedGoogle Scholar
- Sears DM, Avots-Avotins A, Culp K, Gavin MW: Frequency and clinical outcome of capsule retention during capsule endoscopy for GI bleeding of obscure origin. Gastrointest Endosc. 2004, 60: 822-827. 10.1016/S0016-5107(04)02019-X.View ArticlePubMedGoogle Scholar
- Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, Lewis BS: The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease. Am J Gastroenterol. 2006 Oct, 101 (10): 2218-2222. 10.1111/j.1572-0241.2006.00761.x.View ArticlePubMedGoogle Scholar
- Storch I, Barkin JS: Contraindications to capsule endoscopy: do any still exist?. Gastrointest Endosc Clin N Am. 2006, 16: 329-336. 10.1016/j.giec.2006.01.017.View ArticlePubMedGoogle Scholar
- Delvaux M, Ben Soussan E, Laurent V, Lerebours E, Gay G: Clinical evaluation of the use of the M2A patency capsule system before a capsule endoscopy procedure, in patients with known or suspected intestinal stenosis. Endoscopy. 2005, 37: 801-807. 10.1055/s-2005-870241.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.